| Autor: |
Jin S; pRED Inflammation Discovery Therapeutic Area, Hoffmann-La Roche, Nutley, New Jersey, USA., Chin J, Seeber S, Niewoehner J, Weiser B, Beaucamp N, Woods J, Murphy C, Fanning A, Shanahan F, Nally K, Kajekar R, Salas A, Planell N, Lozano J, Panes J, Parmar H, DeMartino J, Narula S, Thomas-Karyat DA |
| Jazyk: |
angličtina |
| Zdroj: |
Mucosal immunology [Mucosal Immunol] 2013 Sep; Vol. 6 (5), pp. 886-99. Date of Electronic Publication: 2012 Dec 19. |
| DOI: |
10.1038/mi.2012.124 |
| Abstrakt: |
Tumor necrosis factor (TNF)-like cytokine 1A (TL1A)/TNF superfamily member 15 (TNFSF15) is a proinflammatory cytokine and TNFα superfamily member that is linked preclinically and clinically to inflammatory bowel disease (IBD). By homology and function, TNFα is its closest family member. In this study, we investigated the mechanism of TL1A-induced inflammation in CD4+ T cells and compared it with the TNFα pathway. We found that TL1A induces proinflammatory cytokines, including TNFα, from isolated human CD4+CD161+ T cells, whereas these cells were resistant to TNFα treatment. Anti-TNFα failed to block TL1A-induced cytokine production, indicating that the effects of TL1A are direct. Lastly, CD161 and TL1A expression were significantly and selectively increased in gut tissue biopsies, but not in the peripheral blood, from IBD patients. Thus, TLIA not only functions upstream of TNFα, driving its expression from CD161+ T cells, but is also independent of TNFα. These findings may have therapeutic IBD implications. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
